JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition.

J Clin Invest · 2018 · PMC5785272 · PMID 29355841

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Gata2 levels showed a trend toward increased expression in mice treated with IDH inhibition ( Figure 5F ), consistent with results in Tet2-mutant AML ( 15 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.